Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
Jenny Furlanetto, Volker Möbus, Andreas Schneeweiß, Kerstin Rhiem, Hans Tesch, Jens‐Uwe Blohmer, Kristina Lübbe, Michael Untch, Christoph Salat, Jens Huober, Peter Klare, Rita K. Schmutzler, Fergus J. Couch, Bianca Lederer, Bernd Gerber, Dirk-Michael Zahm, Ingo Bauerfeind, Valentina Nekljudova, Claus Hanusch, Christian Jackisch, Theresa Link, Eric Hahnen, Sibylle Loibl, Peter A. Fasching
Topics & Concepts
MedicineChemotherapyOncologyBreast cancerGermlineInternal medicineGermline mutationCancerMutationGeneBiologyGeneticsBRCA gene mutations in cancerPARP inhibition in cancer therapyBreast Cancer Treatment Studies